• Yan-Wei Zeng, Chao Liu, Mei-Pan Yin, Yue Zhao, Zhi-Wei Wang, Peng-Li Zhou, Yao-Zhen Ma, Chun-Xia Li, and Gang Wu.
• Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
• J Vasc Surg Venous Lymphat Disord. 2020 Nov 1; 8 (6): 945-952.

ObjectiveOur study aimed to evaluate the safety and efficacy of sequential interventional therapy for Budd-Chiari syndrome (BCS) caused by obstruction of the inferior vena cava (IVC) with fresh thrombus in the IVC.MethodsFull medical records were obtained for 20 patients with BCS associated with fresh IVC thrombus who received sequential interventional therapy from 2014 to 2019 at our hospital. All patients underwent small-diameter percutaneous transluminal angioplasty (PTA) balloon catheter predilation combined with sequential catheter-directed thrombolysis and large-diameter PTA balloon dilation. Ultrasound examinations were performed at 1 week, 1 month, 3 months, and every 6 months thereafter. Therapeutic effects and perioperative and postoperative adverse effects were recorded to assess the safety of the treatment.ResultsAll 20 patients were treated with small PTA balloon catheters (diameter, 10-14 mm) to predilate the occlusive segment of the IVC. Urokinase 400,000 to 600,000 (465,000 ± 93,000) units was administered to patients through the catheter for 6 to 20 (9.7 ± 4.2) consecutive days postoperatively. Ultrasound re-examination showed that the IVC thrombus disappeared completely in 14 patients (70.0%), and a small amount of the old thrombus remained in 6 patients (30.0%). After thrombolysis, all 20 patients received PTA balloon dilation (diameter, 26-30 mm) in the stenosed IVC segment, and blood flow recovered subsequently. No pulmonary embolism or death occurred in the perioperative course. The perioperative survival rate was 100.0%.ConclusionsSequential interventional therapy for BCS associated with fresh IVC thrombus is safe and effective.Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

30 keywords...

hide…